Detalhe da pesquisa
1.
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
J Infect Dis
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682569
2.
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.
J Infect Dis
; 225(9): 1521-1532, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33319249
3.
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).
Clin Infect Dis
; 75(1): 107-117, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606595
4.
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
N Engl J Med
; 381(21): 2009-2019, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31693803
5.
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Lancet
; 395(10234): 1423-1433, 2020 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197105
6.
Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City.
Rev Panam Salud Publica
; 45: e67, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34131423
7.
Safety of Dengue Vaccine?
Clin Infect Dis
; 76(4): 771-772, 2023 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196620
8.
Tetravalent Dengue Vaccine in Healthy Children. Reply.
N Engl J Med
; 382(18): 1770-1771, 2020 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348660
9.
Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study.
Eur Respir J
; 46(3): 783-94, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26113676
10.
Pharmacokinetic and pharmacodynamic interaction of siponimod (BAF312) and propranolol in healthy subjects.
Int J Clin Pharmacol Ther
; 53(10): 855-65, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308174
11.
Effect of oral siponimod (BAF312) on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in healthy female subjects.
Int J Clin Pharmacol Ther
; 52(11): 996-1004, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25161159
12.
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Glob Health
; 12(2): e257-e270, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245116
13.
Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue.
Am J Trop Med Hyg
; 108(4): 722-726, 2023 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878213
14.
Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults.
NPJ Vaccines
; 8(1): 75, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230978
15.
A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
Clin Ther
; 29(12): 2677-84, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18201583
16.
Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation.
Clin Pharmacol Drug Dev
; 5(1): 76-82, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27119581
17.
Bioavailability of valsartan oral dosage forms.
Clin Pharmacol Drug Dev
; 3(2): 132-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27128457
18.
Longterm efficacy of topical nonsteroidal antiinflammatory drugs in knee osteoarthritis: metaanalysis of randomized placebo controlled clinical trials.
J Rheumatol
; 33(9): 1841-4, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16960944